Sign In
Buy MYOV
$26.98
+0 (+0%)
At Close: Jun 08, 2023
Myovant Sciences and Pfizer Announce Publication in The Lancet of Phase 3 SPIRIT 1 and SPIRIT 2 Studies of Once-Daily Relugolix Combination Therapy in Women With Endometriosis-Associated Pain
10:45am, Friday, 17'th Jun 2022 GlobeNewswire Inc.
BASEL, Switzerland and NEW YORK, June 17, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV) and Pfizer Inc. (NYSE: PFE) today announced that results of the Phase 3 SPIRIT 1 and SPIRIT 2 studies
Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
08:35pm, Thursday, 16'th Jun 2022 GlobeNewswire Inc.
BASEL, Switzerland, June 16, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a biopharmaceutical company that aspires to redefine care for women and for men through purpose-driven science,
Myovant Sciences to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference
10:50am, Friday, 03'rd Jun 2022 GlobeNewswire Inc.
BASEL, Switzerland, June 03, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a biopharmaceutical company that aspires to redefine care for women and for men through purpose-driven science,
Myovant Sciences to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference
06:50am, Friday, 03'rd Jun 2022
BASEL, Switzerland, June 03, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a biopharmaceutical company that aspires to redefine care for women and for men through purpose-driven science, em
Myovant Sciences and Pfizer Announce FDA Acceptance of Supplemental New Drug Application for MYFEMBREE®
10:50am, Thursday, 02'nd Jun 2022 GlobeNewswire Inc.
BASEL, Switzerland and NEW YORK, June 02, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV) and Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) accep
Myovant Sciences Ltd. (MYOV) Q4 2021 Earnings Call Transcript
07:00am, Wednesday, 11'th May 2022 The Motley Fool
MYOV earnings call for the period ending March 31, 2022.
Myovant Sciences Ltd. (MYOV) CEO Dave Marek on Q4 2021 Results - Earnings Call Transcript
03:36pm, Tuesday, 10'th May 2022
Myovant Sciences Ltd. (NYSE:MYOV ) Q4 2021 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants Uneek Mehra - Chief Financial & Business Officer Dave Marek - Chief Executive Officer L
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
01:23pm, Tuesday, 10'th May 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Pfizer Acquires Biohaven For $11B
Pfizer Inc (NYSE: PFE) will acquire Biohaven Pharmaceutical Hold
Myovant Sciences (MYOV) Reports Q4 Loss, Misses Revenue Estimates
12:05pm, Tuesday, 10'th May 2022 Zacks Investment Research
Myovant Sciences (MYOV) delivered earnings and revenue surprises of -14.55% and 5.26%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Myovant Sciences Announces Corporate Updates and Financial Results for Fourth Fiscal Quarter and Fiscal Year Ended March 31, 2022
10:55am, Tuesday, 10'th May 2022 GlobeNewswire Inc.
BASEL, Switzerland, May 10, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a biopharmaceutical company that aspires to redefine care for women and for men through purpose-driven science, e
Myovant Sciences (MYOV) Reports Q4 Loss, Misses Revenue Estimates
09:47am, Tuesday, 10'th May 2022
Myovant Sciences (MYOV) delivered earnings and revenue surprises of -14.55% and 5.26%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Myovant Sciences and Accord Healthcare, Ltd. Enter into Exclusive License Agreement to Commercialize ORGOVYX® for Advanced Hormone-Sensitive Prostate Cancer in Europe
10:30am, Monday, 09'th May 2022 GlobeNewswire Inc.
BASEL, Switzerland and HARROW, United Kingdom, May 09, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV) and Accord Healthcare, Ltd. (Accord) today announced that they have entered into an e
Myovant Sciences and Pfizer Provide Update on Supplemental New Drug Application (sNDA) for MYFEMBREE® for the Management of Moderate to Severe Pain Associated With Endometriosis
10:45am, Friday, 06'th May 2022 GlobeNewswire Inc.
BASEL, Switzerland, and NEW YORK, May 06, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV) and Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has exte
Will Myovant Sciences (MYOV) Report Negative Earnings Next Week? What You Should Know
07:00pm, Tuesday, 03'rd May 2022 Zacks Investment Research
Myovant Sciences (MYOV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Myovant Sciences (MYOV) Report Negative Earnings Next Week? What You Should Know
04:33pm, Tuesday, 03'rd May 2022
Myovant Sciences (MYOV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
